According to GlobalData’s medical device pipeline database, nine Suture Anchors devices are in various stages of development globally. GlobalData’s report Suture Anchors provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, eight are in active development, while the remaining one is in an inactive stage of development. There are six products in the early stages of development, and the remaining two are in the late stages of development.
Suture Anchors allow for the fixation of soft tissue, such as ligaments and tendons to bone. These implants are screwed into bone and are attached to sutures which are used to attach to soft tissue. Suture Anchor Implants include one suture anchor with sutures, one tubing set and one cannula. One unit refers to one Suture Anchor Implant.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Suture Anchors pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Suture Anchors devices. Overall, most of these Suture Anchors pipeline devices are being developed by private entities.
Key players involved in the active development of Suture Anchors include KeriMedical, Magnesium Development Company, Parcus Medical, Parcus Medical, San Francisco VA Medical Center, SINTX Technologies, University of Pittsburgh, DePuy Synthes and Hospital for Special Surgery.
For a complete picture of the developmental pipeline for Suture Anchors devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
